Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fulcrum Therapeutics (FULC) Preferred Dividend Payments (2019)

Fulcrum Therapeutics (FULC) has disclosed Preferred Dividend Payments for 1 consecutive years, with $796000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to $796000.0 in Q3 2019 year-over-year; TTM through Dec 2019 was $7.1 million, a N/A change, with the full-year FY2019 number at $7.1 million, up 8.68% from a year prior.
  • Preferred Dividend Payments was $796000.0 for Q3 2019 at Fulcrum Therapeutics, down from $3.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $3.3 million in Q2 2019 to a low of $796000.0 in Q3 2019.